Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial

Purpose Nuclear imaging plays a crucial role in lymphatic mapping of oral cancer. This evaluation represents a subanalysis of the original multicenter SENT trial data set, involving 434 patients with T1-T2, N0, and M0 oral squamous cell carcinoma. The impact of acquisition techniques, tracer injection timing relative to surgery, and causes of false-negative rate were assessed. Methods Three to 24 hours before surgery, all patients received a dose of 99mTc-nanocolloid (10–175 MBq), followed by lymphoscintigraphy. According to institutional protocols, all patients underwent preoperative dynamic/static scan and/or SPECT/CT. Results Lymphoscintigraphy identified 723 lymphatic basins. 1398 sentinel lymph nodes (SNs) were biopsied (3.2 SN per patient; range, 1–10). Dynamic scan allowed the differentiation of sentinel nodes from second tier lymph nodes. SPECT/CT allowed more accurate anatomical localization and estimated SN depth more efficiently. After pathological examination, 9.9% of the SN excised (138 of 1398 SNs) showed metastases. The first neck level (NL) containing SN+ was NL I in 28.6%, NL IIa in 44.8%, NL IIb in 2.8%, NL III in 17.1%, and NL IV in 6.7% of positive patients. Approximately 96% of positive SNs were localized in the first and second lymphatic basin visualized using lymphoscintigraphy. After neck dissection, the SN+ was the only lymph node containing metastasis in approximately 80% of patients. Conclusions Best results were observed using a dynamic scan in combination with SPECT/CT. A shorter interval between tracer injection, imaging, and surgery resulted in a lower false-negative rate. At least 2 NLs have to be harvested, as this may increase the detection of lymphatic metastases.

[1]  C. von Buchwald,et al.  Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: A retrospective single‐center study , 2016, Head & neck.

[2]  S. Stoeckli,et al.  Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. , 2015, European journal of cancer.

[3]  S. Stoeckli,et al.  Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma , 2015, Head & neck.

[4]  B. Al-Nawas,et al.  Sentinel lymph node biopsy in T1/T2 squamous cell carcinomas of the tongue: A prospective study , 2015, Oncology letters.

[5]  Jann Mortensen,et al.  Feasibility of Real-Time Near-Infrared Fluorescence Tracer Imaging in Sentinel Node Biopsy for Oral Cavity Cancer Patients , 2015, Annals of Surgical Oncology.

[6]  Sudeep Gupta,et al.  Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. , 2015, The New England journal of medicine.

[7]  K. Pitman,et al.  [99mTc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial , 2015, Annals of Surgical Oncology.

[8]  M. McGurk,et al.  Three‐dimensional imaging and navigated sentinel node biopsy for primary parotid malignancy: New application in parotid cancer management , 2014, Head & neck.

[9]  O. Hoekstra,et al.  Practice variation in defining sentinel lymph nodes on lymphoscintigrams in oral cancer patients , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  G. Mariani,et al.  Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from "open and see" to "see and open". , 2014, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[11]  S. Stoeckli,et al.  Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: Impact on survival , 2013, Head & neck.

[12]  R. de Bree,et al.  Visualization of the sentinel node in early-stage oral cancer: limited value of late static lymphoscintigraphy , 2012, Nuclear medicine communications.

[13]  Chi-Te Wang,et al.  Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck—a meta-analysis comparing different imaging modalities , 2012, BMC Cancer.

[14]  S. Leong.  Role of selective sentinel lymph node dissection in head and neck melanoma , 2011, Journal of surgical oncology.

[15]  S. Stoeckli,et al.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  P. Sloan.  Head and Neck Sentinel Lymph Node Biopsy: Current State of the Art , 2009, Head and neck pathology.

[17]  S. Singer,et al.  Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection , 2009, Head & neck.

[18]  D. Rubello,et al.  The impact of superficial injections of radiocolloids and dynamic lymphoscintigraphy on sentinel node identification in oral cavity cancer: a same-day protocol , 2008, Nuclear medicine communications.

[19]  F. Civantos,et al.  Sentinel node biopsy in oral squamous cell carcinoma , 2007, Journal of surgical oncology.

[20]  S. Stoeckli.  Sentinel Node Biopsy for Oral and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck , 2007, The Laryngoscope.

[21]  G. Tartaglione,et al.  Lymphoscintigraphy and radioguided sentinel node biopsy in oral cavity squamous cell carcinoma: same day protocol , 2006, European Archives of Oto-Rhino-Laryngology.

[22]  J. Marving,et al.  The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer , 2006, Acta oto-laryngologica.

[23]  S. Stoeckli,et al.  The Second International Conference on Sentinel Node Biopsy in Mucosal Head and Neck Cancer , 2005, Annals of Surgical Oncology.

[24]  T. Poli,et al.  Role of intra-operative sentinel lymph node biopsy in oral cavity and oropharynx squamous cell carcinoma: preliminary data. , 2003, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[25]  K. Pitman,et al.  Sentinel Lymph Node Biopsy in Head and Neck Squamous Cell Carcinoma , 2002, The Laryngoscope.

[26]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[27]  M. Maggiore,et al.  Lymphatic Mapping and Sentinel Node Identification in Squamous Cell Carcinoma and Melanoma of the Head and Neck , 2002, Tumori.

[28]  S. Stoeckli,et al.  Sentinel Lymph Node Evaluation in Squamous Cell Carcinoma of the Head and Neck , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[29]  R. Wahl,et al.  Sentinel node localization in oral cavity and oropharynx squamous cell cancer. , 2001, Archives of otolaryngology--head & neck surgery.

[30]  D. Soutar,et al.  The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck , 2001, Cancer.

[31]  D. Krag,et al.  Sentinel Lymph Node Radiolocalization in Head and Neck Squamous Cell Carcinoma , 2000, The Laryngoscope.

[32]  H. Pillsbury,et al.  A Rationale for Therapy of the N0 Neck , 1997, The Laryngoscope.

[33]  H. Stähelin.  Guidelines , 1994, Communicating Science.

[34]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[35]  J. Shah,et al.  Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. , 1990, American journal of surgery.

[36]  B. Pacella,et al.  Rationale for elective neck dissection in 1990 , 1990, The Laryngoscope.

[37]  W. Sawyer,et al.  Objective comparison of physical dysfunction after neck dissection. , 1985, American journal of surgery.

[38]  J. Teichgraeber,et al.  The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale. , 1984, Head & neck surgery.

[39]  Cornelis J H van de Velde,et al.  Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients. , 2013, Oral oncology.

[40]  Josef Machac,et al.  Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas, and analysis of images. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[41]  K. Pitman.  Rationale for elective neck dissection. , 2000, American journal of otolaryngology.

[42]  G. Snow,et al.  Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor , 1994, Cancer.

[43]  D. Krag,et al.  Gamma-probe guided localization of lymph nodes. , 1993, Surgical oncology.

[44]  R M Byers,et al.  Rationale for elective modified neck dissection. , 1988, Head & neck surgery.